TrialOral oncology2022

Pharmacodynamic and therapeutic pilot studies of single-agent ribavirin in patients with human papillomavirus-related malignancies.

Bharat Burman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.